Last edition
News about "Evax AG"
Boehringer Ingelheim Acquires Swiss Biotech Evax to Advance Therapeutic Vaccines for Equine Health
Boehringer Ingelheim has acquired Swiss biotech Evax AG to advance virus-like particle-based therapeutic vaccines aimed at addressing allergic skin diseases and other unmet health needs in horses.
Evax AG | 12/08/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members